Becton Dickinson & Co (NYSE:BDX)
$ 235.67 0.67 (0.29%) Market Cap: 68.11 Bil Enterprise Value: 82.95 Bil PE Ratio: 51.91 PB Ratio: 2.65 GF Score: 80/100

Becton Dickinson and Co at Evercore ISI HealthCONx Conference Transcript

Dec 02, 2020 / 01:00PM GMT
Release Date Price: $235.81 (+1.35%)
Vijay Muniyappa Kumar
Evercore ISI Institutional Equities, Research Division - MD

Okay. Thanks, everyone, for joining us this morning. We're kicking off day 2 of our HealthCONx conference with Becton, Dickinson, a favorite company of mine. I cover devices and life sciences, I don't find too many companies that wearing that [cross hat], BD happens to be one of them.

So representing the company, we have CEO, Tom Polen; CFO, Chris Reidy. And from Interventional, we have Simon Campion; and Dave Hickey from Life Sciences. So gentlemen, thanks so much for participating this morning.

And before I forget, we do have, I think in the background, Kristen Stewart. Kristen, this must be a deja vu for you doing this from the other side. But I think you had some opening comments to make, so maybe I'll let you start off, and then we can get into Q&A.

Kristen Marie Stewart
Becton, Dickinson and Company - SVP of Strategy & IR

Thanks, Vijay. So this is my new fun thing to do at these conferences, reading the disclaimers. So today's presentation, we

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot